These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19275037)

  • 21. Highly purified calf hemodialysate (Actovegin®) may improve endothelial function by activation of proteasomes: A hypothesis explaining the possible mechanisms of action.
    Stelmakh A; Abrahamovych O; Cherkas A
    Med Hypotheses; 2016 Oct; 95():77-81. PubMed ID: 27692173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The efficacy of membrane-stabilizing therapy in bronchial asthma].
    Abdusalamov AB; Shafer AM
    Ter Arkh; 1994; 66(3):32-4. PubMed ID: 8202848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic neuroprotective and metabolic effects of Actovegin's mode of action.
    Machicao F; Muresanu DF; Hundsberger H; Pflüger M; Guekht A
    J Neurol Sci; 2012 Nov; 322(1-2):222-7. PubMed ID: 22910148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Our experience on Actovegin, is it cutting edge?
    Lee P; Rattenberry A; Connelly S; Nokes L
    Int J Sports Med; 2011 Apr; 32(4):237-41. PubMed ID: 21271496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamics of endothelial function and markers of hypoxia in children with the facial nerve palsy during treatment].
    Pityk MI; Liskevych II
    Lik Sprava; 2013; (7):53-7. PubMed ID: 25509915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypoxia as a pharmacological problem].
    Vinogradov VM; Uriupov IuIu
    Farmakol Toksikol; 1985; 48(4):9-20. PubMed ID: 3899720
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of actovegin in the neuroprotective treatment of patients with cerebrovascular diseases].
    Shavlovskaia OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):74-6. PubMed ID: 23887455
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of adjuvant infusion therapy of low molecular weight dextrans (Infukoll M 40) and deproteinized hemoderivate (Actovegin) in Fontaine stage IV chronic arterial occlusive diseases].
    Stoltz J; Bartel M
    Zentralbl Chir; 1988; 113(16):1044-55. PubMed ID: 2461011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Some aspects of substantiation of an individual approach to the treatment of primary ischemic stroke].
    Tkachenko OV; Ts'okha IO
    Lik Sprava; 2010; (1-2):102-6. PubMed ID: 20614513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stimulation of cell cultures recovery after cryopreservation by the cattle cord blood FRACTION (below 5 kDa) or Actovegin].
    Gulevskiĭ AK; Trifonova AV; Lavrik AA
    Tsitologiia; 2013; 55(9):619-25. PubMed ID: 25470939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of the combined therapy with citicholine and actovegin in the acute period of ischemic stroke].
    Shamalov NA; Stakhovskaia LV; Shetova IM; Efremova NM; Anisimov KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):13-7. PubMed ID: 21462435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The korinfar and actovegin treatment of patients with a chronic ischemic disorder of the cerebral circulation].
    Vesel'skiĭ ISh; Sanik AV
    Lik Sprava; 1992 Jun; (6):116-9. PubMed ID: 1455818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The diagnosis of microcirculatory-rheological disorders and their correction in patients with the initial manifestations of insufficiency of the cerebral blood supply].
    Vesel'skiĭ ISh; Sanik AV; Nasonova TI
    Lik Sprava; 1995; (9-12):87-9. PubMed ID: 8983804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.
    Dieckmann A; Kriebel M; Andriambeloson E; Ziegler D; Elmlinger M
    Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):132-8. PubMed ID: 22020669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intraocular correction of aphakia in patients after kidney transplantation].
    Bocharov VE; Ivanov MN; Gantsovskiĭ PI
    Vestn Oftalmol; 2004; 120(4):21-4. PubMed ID: 15384842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypoxic activity of the novel intraorganoid pharmacological preparation mitochondrin].
    Makarenko AN; Klebanskiĭ EO; Shirobokova LP
    Eksp Klin Farmakol; 2002; 65(1):68-72. PubMed ID: 12025792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actovegin®: a biological drug for more than 5 decades.
    Buchmayer F; Pleiner J; Elmlinger MW; Lauer G; Nell G; Sitte HH
    Wien Med Wochenschr; 2011 Feb; 161(3-4):80-8. PubMed ID: 21404144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of pharmacopuncture on the blood biochemical indices of patients with tunnel syndromes of the hands].
    Belitskaia RA; Vasilenko GF; Krasnova LB; Popkova EV; Chuzavkova EA; Agasarov LG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (5):14-7. PubMed ID: 10598522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stimulatory effect of the cord blood fraction below 5 kDa and "Actovegin" on the growth of continuous cell lines].
    Gulevskiĭ AK; Trifonova AV; Lavrik AA
    Tsitologiia; 2011; 53(2):135-41. PubMed ID: 21516820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.